You are here: Home » PTI Stories » National » News
Business Standard

Unichem Labs gets USFDA nod to market Allopurinol tablets

Press Trust of India  |  New Delhi 

Drug firm Wednesday said it has received approval from the US health regulator to market its tablets.

The company has received approval from the Food and Drug Administration (USFDA) to market generic tablets in the strengths of 100 mg and 300 mg, said in a filing to BSE.

The tablets are generic version of talets, it added.

The product will be commercialised from company's Ghaziabad plant, said.

The tablets are indicated for management of patients with signs and symptoms of primary or and those with leukemia, and malignancies who are receiving therapy which causes elevations of serum and urinary uric acid levels among others.

Shares of Unichem Laboratories closed at Rs 204.75 per scrip on BSE, up 1.16 per cent from their previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, March 13 2019. 16:45 IST